Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

68.62
Delayed Data
As of 4:02pm ET
 -0.34 / -0.49%
Today’s Change
67.28
Today|||52-Week Range
88.49
-20.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line1.0B2.0B1.8B2.0B
 
 
 
 
 
Depreciation1.0B1.3B1.5B1.5B
 
 
 
 
 
Total Other Cash Flow-336.0M299.9M93.4M-119.7M
 
 
 
 
 
Funds From Operations1.7B3.6B3.4B3.4B
 
 
 
 
 
Funds From/For Other Operating Expenses-2.4B2.1B282.6M116.0M
 
 
 
 
 
Net Cash Flow - Operating Activities4.1B1.5B3.1B3.3B
 
 
 
 
 
 
InvestingIncrease In Investments-710.7M0.000.000.00
 
 
Decrease In Investments427.2M0.000.0089.2M
 
 
 
Capital Expenditures-740.8M-377.3M-452.2M-449.6M
 
 
 
 
 
Fixed Asset Disposal236.6M518.5M97.9M343.9M
 
 
 
 
 
Net Assets From Acquisitions -24.7M-405.8M-18.5M-107.1M
 
 
 
 
 
Other Investing - Uses845.7M-521.4M-484.4M482.5M
 
 
 
 
 
Other Investing - Sources-523.2M29.4M4.5M-33.9M
 
 
 
 
 
Net Cash Flow Investing-1.6B-756.6M-852.6M-764.5M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.00------
Long Term Borrowings1.9B5.5B-1.5B109.1M
 
 
 
 
 
Long Term Debt Reduction-3.1B0.000.00--
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-3.6B-180.3M-98.5M-412.8M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total44.7M-6.3B-101.7M-42.7M
 
 
 
 
 
Other Sources - Financing1.6B0.005.0M-5.0M
 
 
 
 
Other Uses - Financing-29.2M28.4M-28.4M9.0M
 
 
 
 
 
Net Cash Flow - Financing-2.7B-1.0B-1.7B-360.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-345.8M39.2M-45.2M962.9K
 
 
 
 
 
 
Net Change In Cash-255.3M-251.9M618.3M2.1B